These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
4. A 2-Benzylmalonate Derivative as STAT3 Inhibitor Suppresses Tumor Growth in Hepatocellular Carcinoma by Upregulating β-TrCP E3 Ubiquitin Ligase. Peng T; Wonganan O; Zhang Z; Yu J; Xi R; Cao Y; Suksamrarn A; Zhang G; Wang F Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805945 [TBL] [Abstract][Full Text] [Related]
5. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway. Shen ZT; Chen Y; Huang GC; Zhu XX; Wang R; Chen LB BMC Cancer; 2019 Nov; 19(1):1075. PubMed ID: 31703572 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis. Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864 [TBL] [Abstract][Full Text] [Related]
7. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation. Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501 [TBL] [Abstract][Full Text] [Related]
8. Elevated TRAF2/6 expression in Parkinson's disease is caused by the loss of Parkin E3 ligase activity. Chung JY; Park HR; Lee SJ; Lee SH; Kim JS; Jung YS; Hwang SH; Ha NC; Seol WG; Lee J; Park BJ Lab Invest; 2013 Jun; 93(6):663-76. PubMed ID: 23608757 [TBL] [Abstract][Full Text] [Related]
9. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis. Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098 [TBL] [Abstract][Full Text] [Related]
12. Baohuoside I Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Apoptosis Signaling and NF-kB Pathway. Sun Y; Pang B; Wang Y; Xiao J; Jiang D Chem Biodivers; 2021 Jun; 18(6):e2100063. PubMed ID: 33904248 [TBL] [Abstract][Full Text] [Related]
13. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro. Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma. Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930 [TBL] [Abstract][Full Text] [Related]
15. PIGU promotes hepatocellular carcinoma progression through activating NF-κB pathway and increasing immune escape. Wei X; Yang W; Zhang F; Cheng F; Rao J; Lu L Life Sci; 2020 Nov; 260():118476. PubMed ID: 32971102 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells. Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494 [TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Ganten TM; Koschny R; Haas TL; Sykora J; Li-Weber M; Herzer K; Walczak H Hepatology; 2005 Sep; 42(3):588-97. PubMed ID: 16037944 [TBL] [Abstract][Full Text] [Related]
19. The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis. Wang X; Rusin A; Walkey CJ; Lin JJ; Johnson DL J Biol Chem; 2019 Dec; 294(50):19255-19268. PubMed ID: 31645432 [TBL] [Abstract][Full Text] [Related]
20. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate. Hou H; Li WX; Cui X; Zhou DC; Zhang B; Geng XP World J Gastroenterol; 2019 Sep; 25(36):5483-5493. PubMed ID: 31576094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]